Cerebral Embolic Protection in TAVR

Northwell Fellows Course 2020

A. Tariq

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Intra-Aortic Balloon Pump: New Insights

David Baran

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

SCAI SHOCK 2023: Strategies to Disrupt SCAI Stage B Progression

Getinge

J. O'Grady, J. Katz, N. Kapur, A. Dupont, R. Kataria

Femoral Access

Northwell Fellows Course 2020

M. Kim

HFSA 2023 - Intra-Aortic Balloon Pump – Bridge to Heart Transplant.

Getinge

C. Gidea

HFSA 2023 - Counterpulsation Applications in Heart Failure: Restrict…

Getinge

R. Lee

HFSA 2023 - Physiological and Clinical Effects of Counterpulsation i…

Getinge

I. Isseh

HFSA 2023 - Navigating MCS Selection Amidst the RCT Evidence Gap.

Getinge

D. Baran

The Other Option for Hemodynamic Support in High Risk PCI

Joseph Thomas

ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …

Insights from 2024 ACP Annual Meeting

D. Berg

Incorporating Coronary Physiology in Decision Making

San Diego Cardiovascular Interventions (SDCI) 2017

M. Kern

Common Issues with IABP and How to Troubleshoot Them

Getinge

A. Klein

Cardiogenic Shock: Treatment Options

NYU Langone

S. Hall

Expanded Indications of Impella Protected PCI

Complex Coronary Cases

J. Lasala

HFSA 2023 - Reviving Hearts, Renewing Lives the Evolution of Counter…

Getinge

I. Isseh, C. Gidea, R. Lee, D. Baran